首页> 新闻动态> 前海安测获批设立深圳市博士后创新实践基地

前海安测获批设立深圳市博士后创新实践基地

2020-02-22 15:26

2020年2月22日消息,根据深圳市人力资源和社会保障局下发的《深圳市人力资源和社会保障局关于批准深圳市投资控股有限公司等75家单位设立博士后创新实践基地(市级)的通知》(深人社发[2020] 5号),易特科集团旗下子公司——深圳市前海安测信息技术有限公司经过层层评估,获批设立深圳市博士后创新实践基地!

深圳市博士后创新实践基地是深圳市人力资源和社会保障局批准设立的博士后科研工作平台,是培养、吸引高层次创新型人才的重要载体。前海安测获批设立博士后创新基地,是在相继获批院士工作站、博士工作站后的又一重大成果,标志着企业科研水平和技术创新能力的进一步提升。


前海安测是聚焦于医疗卫生信息化与智能化领域的软硬件产品研发、生产、销售、实施及整体解决方案技术提供商, 是全国智慧医疗行业中知识产权、人才培养和科研实力突出的骨干企业之一。

一、知识产权:3100多项知识产权在智慧医疗细分领域全球领先

知识产权是前海安测的核心无形资产,前海安测十分注重知识产权的开发与保护。截至目前,公司在“AI+医疗+健康+养老”领域已申请/拥有各类知识产权3100多项,以高技术含量的发明和国际PCT专利为主(占专利总量65%以上),技术覆盖生物IT、医疗信息化、大数据、云计算、物联网、医疗器械、肿瘤筛查、新型生物传感器及人工智能等领域。

前海安测是国家、广东省和深圳市知识产权优势企业、广东省知识产权示范企业,并获得六项中国专利优秀奖。专利申请数量在智慧医疗细分领域排在国内第一、世界第四,集团子公司易特科在2019年全球数字医疗科技发明专利排行榜(TOP100)中位于中国第3、全球第14,集团四家子公司入选2018中国企业PCT国际专利申请排行榜TOP100。

二、人才培养:50余名院士、教授、博士和研发人员组成研发骨干队伍

自成立以来,前海安测一直秉承"创新驱动·技术引领"的经营理念,与国内外众多知名高校、研究机构、知名企业和科学家团队建立了广泛的合作关系,在智慧医疗和健康养老领域持续创新和产业化应用。目前,公司拥有50余名中外院士、教授、博士和研发人员组成的科研队伍,拥有院士工作站、博士工作站,为社会联合培养了大批智慧医疗领域优秀的实用性高技术人才。根据集团规划,前海安测还将以更加优惠条件吸引更多国内外博士加盟,陆续引进海内外顶尖博士科学家团队、外籍科学家和海内外专家,专门从事医疗信息化和医疗智能化领域的科学研究与创新,力争在技术创新、服务创新、管理创新、运营模式创新等方面继续走在世界同行业前列。

前海安测博士后创新实践基地的创建,将吸纳更多智慧医疗领域顶尖技术人才,以前海安测重大科技项目为载体,共同参与智慧医疗新产品、新技术的研究,加快产学研融合,加速科技成果转化,更好地为国内外大型医院和健康管理中心客户提供技术指导和支持,提升临床医学的效率、效力和效益。

三、科研合作:参与国家级重大科研项目

前海安测曾参与多项国家和省市级科研项目,包括互联网+健康养老创新与应用项目、互联网+医疗创新应用示范项目、科技跨界养老平台项目、肺癌个性化筛查AI云平台项目、糖尿病及其并发症早期诊断和预防传感器研发及产业化项目等,目前在重点推进肺癌AI-CAD诊断系统研发、大湾区中医科学院建设,正在与多家科研机构和综合医院进行合作研究,未来将全面推动我国智慧医疗事业发展!

今后,前海安测将继续加大临床和科研投入力度,不断深化与国内已设立博士后科研流动站的高校、科研院所之间的务实合作,完善博士后工作管理制度,为博士后科研人员营造良好的科研环境,确保科研项目顺利开展,加速科技成果转化,重点推动智慧医疗产业发展。

Qianhai AnyCheck Was Approved to Establish Shenzhen Postdoctoral Innovation Practice Base

On February 22th, 2020, according to the "Shenzhen Human Resources and Social Security Bureau on the approval of Shenzhen Investment Holding Co., Ltd. and other 75 units to set up post-doctoral innovation practice bases (municipal level) issued by the Shenzhen Human Resources and Social Security Bureau. Notice", Shenzhen Qianhai AnyCheck Information Technology Co., Ltd., a subsidiary of E-Techco Group, was approved to set up a Shenzhen post-doctoral innovation practice base after layers of evaluation.

The Shenzhen Postdoctoral Innovation Practice Base is a postdoctoral research work platform approved by the Shenzhen Municipal Bureau of Human Resources and Social Security and an important carrier for training and attracting high-level innovative talents. Qianhai AnyCheck was approved to set up a postdoctoral innovation base, which is another major achievement after successively being approved by academician workstations and doctoral workstations, marking the further improvement of the company's scientific research level and technological innovation capabilities.

Qianhai AnyCheck is a software and hardware product research and development, production, sales, implementation and overall solution technology provider focusing on the field of medical and health informationization and intelligence. One of the enterprises.

1. Intellectual property rights: More than 3,100 intellectual property rights lead the world in the smart medical segment

Intellectual property is the core intangible asset of Qianhai AnyCheck. Qianhai AnyCheck attaches great importance to the development and protection of intellectual property. Up to now, the company has applied for / owned more than 3,100 intellectual property rights in the field of "AI + Medical + Health + Elderly Care", mainly based on high-tech inventions and international PCT patents (accounting for more than 65% of the total patents). Bio IT, medical information technology, big data, cloud computing, Internet of Things, medical devices, tumor screening, new biosensors and artificial intelligence.

Qianhai AnyCheck is a national, Guangdong and Shenzhen Intellectual Property Advantage Enterprise, and Guangdong Intellectual Property Demonstration Enterprise, and has won six Chinese Patent Excellence Awards. The number of patent applications ranks first in China and fourth in the world in the field of smart medical subdivisions. E-Techco, a subsidiary of the group, is ranked 3rd in China and 14th in the world in the TOP100 list of global digital medical technology invention patents in 2019. Four subsidiaries were included in the TOP100 list of 2018 Chinese companies' PCT international patent applications.

2. Talent training: more than 50 academicians, professors, doctors and R & D personnels form the backbone of R & D

Since its establishment, Qianhai AnyCheck has been adhering to the business philosophy of "innovation-driven and technology-led", and has established extensive cooperative relationships with many well-known universities, research institutions, well-known companies and scientists at home and abroad. Innovation and industrial application. At present, the company has a scientific research team consisting of more than 50 academicians, professors, doctors, and R & D personnel at home and abroad. It has academician workstations and doctoral workstations, and has jointly trained a large number of outstanding practical high-tech talents in the field of smart medical care for the society. According to the group plan, Qianhai AnyCheck will also attract more high talents at home and abroad with more favorable conditions. It will gradually introduce top doctorate scientists at home and abroad, foreign scientists and experts at home and abroad, specializing in scientific research in the field of medical informatization and medical intelligence and strive to continue to be at the forefront of the industry in the world in technological innovation, service innovation, management innovation, and operation model innovation.

The establishment of Qianhai AnyCheck's postdoctoral innovation practice base will attract more top technical talents in the field of smart medical care. Previously, any major scientific and technological project of HaiAnCheck will serve as a carrier to jointly participate in the research of new smart medical products and technologies, accelerate the integration of industry, university and research, and accelerate technology. The transformation of results will better provide technical guidance and support to customers at large hospitals and health management centers at home and abroad, and improve the efficiency, effectiveness and efficiency of clinical medicine.

3. Scientific research cooperation: Participate in major national scientific research projects

Qianhai AnyCheck has participated in a number of national, provincial and municipal scientific research projects, including Internet + Healthy Elderly Innovation and Application Project, Internet + Medical Innovation Application Demonstration Project, Technology Cross-Border Elderly Care Platform Project, Lung Cancer Personalized Screening AI Cloud Platform Project, research and development and industrialization projects of early diagnosis and prevention sensors for diabetes and its complications are currently focused on advancing the development of AI-CAD diagnostic systems for lung cancer and the construction of the Greater Bay Area College of Traditional Chinese Medicine. Qianhai AnyCheck cooperated research with many scientific institutions and general hospitals which will fully promote the development of China's smart medical cause.

In the future, Qianhai AnyCheck will continue to increase clinical and scientific research investment, continue to deepen pragmatic cooperation with universities and research institutes that have established postdoctoral research stations in China, improve the postdoctoral work management system, and create a good The scientific research living environment ensures the smooth development of scientific research projects, accelerates the transformation of scientific and technological achievements, and focuses on promoting the development of the smart medical industry.

按年份查询

全部

2020

2019

2018

2017

2016

2015

2014

2013

搜索